Impact Biotech logo
VerifiedBiotechnology Research· Founded 2022

Impact Biotech

ImPact Biotech is focused on the development and launch of Padeliporfin VTP (Vascular Targeted Photodynamic) therapy for the treatment of solid tumors. The company is headquartered in Israel, with presence in Luxembourg, France and USA, as well as its own GMP-certified (Good Manufacturing Practice) facility and research center in Israel. ImPact Biotech holds exclusive rights from the Weizmann Institute of Science (WIS, Israel) and Memorial Sloan Kettering Cancer Center (MSKCC, New York), to develop and commercialize drugs and related technologies used in VTP.

7-day free trial · no credit card

HeadquartersNess Ziona, IsraelEmployees40(51 to 200)Founded year2022Websiteimpactbiotech.comLinkedIn profileLinkedIn

Verified contacts

36

available on Kipplo

LinkedIn employees

40

51 to 200 range

Open roles

no listings

Distinct roles

31

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 36 verified contacts at Impact Biotech

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

36 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Impact Biotech

31 distinct titles indexed · top 10 shown.

  • 2senior qa associate
  • 1accountant
  • 1analytical chemist
  • 1chief executive officer
  • 1chief financial officer
  • 1cmc and rnd qa senior associate
  • 1combination products
  • 1contrôleur de gestion
  • 1engineering manager
  • 1global head of regulatory affairs & vigilance
  • +21more titles

Sign up to unlock all 36 contacts at Impact Biotech

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 36 verified contacts at Impact Biotech

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Impact Biotech | Kipplo Discover